FunPep Company Limited engages in the research and development of pharmaceuticals drugs, functional cosmetics, and medical devices based on functional peptides. The company is developing SR-0379, a functional peptide for skin ulcer; FPP003, an antibody-inducing peptide that is in Phase II clinical study for the treatment of psoriasis in Australia, as well as phase II clinical trial for ankylosing spondylitis in Japan; and FPP004X, an antibody-inducing peptide for pollinosis. It is also developing FPP006, a corona peptide vaccine; and FPP005, a antibody including peptide for psoriasis. FunPep Company Limited was incorporated in 2013 and is based in Tokyo, Japan.
तुलना करने के लिए मीट्रिक्स | 4881 | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंध4881पीअर्सक्षेत्र | |
---|---|---|---|---|
पी/ई अनुपात | −6.2x | −7.0x | −0.6x | |
PEG अनुपात | - | −0.13 | 0.00 | |
क़ीमत/बुक | 1.6x | 4.6x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 1,534.0x | 69.6x | 3.1x | |
अपसाइड (विश्लेषक लक्ष्य) | - | 39.7% | 48.7% | |
उचित मूल्य अपसाइड | अनलॉक करें | 6.3% | 7.7% | अनलॉक करें |